Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Osimani

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Preventive Medicine Reports|February 5, 2016
Safety vs. efficacy assessment of pharmaceuticals: Epistemological rationales and methodsBarbara Osimani
Journal of Evaluation in Clinical Practice|May 23, 2013
Until RCT proven? On the asymmetry of evidence requirements for risk assessmentBarbara Osimani
Drug Safety|December 19, 2014
Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms?Barbara Osimani, Fiorenzo Mignini
International Journal of Environmental Research and Public Health|June 27, 2019
New Insights in Computational Methods for Pharmacovigilance: <i>E-Synthesis</i>, a Bayesian Framework for Causal AssessmentFrancesco De Pretis, Barbara Osimani
Journal of Evaluation in Clinical Practice|June 23, 2025
Redefining Representativeness of a Sample in Causal TermsMichał Sikorski, Alexander Gebharter, Barbara Osimani
Frontiers in Pharmacology|January 11, 2020
E-Synthesis: A Bayesian Framework for Causal Assessment in PharmacosurveillanceFrancesco De Pretis, Jürgen Landes, Barbara Osimani
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 18, 2022
Mass versus personalized medicine against COVID-19 in the "system sciences" eraLaura Teodori, Barbara Osimani, Ciro Isidoro, et al.
American Journal of Physical Medicine & Rehabilitation|December 24, 2011
Disability, human rights, and the International Classification of Functioning, Disability, and Health: systematic reviewMaria Aluas, Elena Colombetti, Barbara Osimani, et al.
Computational Economics|May 16, 2023
Incentives for Research Effort: An Evolutionary Model of Publication Markets with Double-Blind and Open ReviewMantas Radzvilas, Francesco De Pretis, William Peden, et al.
Journal of Clinical Medicine|June 10, 2023
When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three ExamplesDavid E Scheim, Colleen Aldous, Barbara Osimani, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Preventive Medicine Reports|February 5, 2016
Safety vs. efficacy assessment of pharmaceuticals: Epistemological rationales and methodsBarbara Osimani
Journal of Evaluation in Clinical Practice|May 23, 2013
Until RCT proven? On the asymmetry of evidence requirements for risk assessmentBarbara Osimani
Drug Safety|December 19, 2014
Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms?Barbara Osimani, Fiorenzo Mignini
International Journal of Environmental Research and Public Health|June 27, 2019
New Insights in Computational Methods for Pharmacovigilance: <i>E-Synthesis</i>, a Bayesian Framework for Causal AssessmentFrancesco De Pretis, Barbara Osimani
Journal of Evaluation in Clinical Practice|June 23, 2025
Redefining Representativeness of a Sample in Causal TermsMichał Sikorski, Alexander Gebharter, Barbara Osimani
Frontiers in Pharmacology|January 11, 2020
E-Synthesis: A Bayesian Framework for Causal Assessment in PharmacosurveillanceFrancesco De Pretis, Jürgen Landes, Barbara Osimani
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 18, 2022
Mass versus personalized medicine against COVID-19 in the "system sciences" eraLaura Teodori, Barbara Osimani, Ciro Isidoro, et al.
American Journal of Physical Medicine & Rehabilitation|December 24, 2011
Disability, human rights, and the International Classification of Functioning, Disability, and Health: systematic reviewMaria Aluas, Elena Colombetti, Barbara Osimani, et al.
Computational Economics|May 16, 2023
Incentives for Research Effort: An Evolutionary Model of Publication Markets with Double-Blind and Open ReviewMantas Radzvilas, Francesco De Pretis, William Peden, et al.
Journal of Clinical Medicine|June 10, 2023
When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three ExamplesDavid E Scheim, Colleen Aldous, Barbara Osimani, et al.
Pageof 2